{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:57:44Z","timestamp":1790546264218,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260520"],"award-info":[{"award-number":["82260520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860528"],"award-info":[{"award-number":["81860528"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37066","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T02:58:44Z","timestamp":1724900324000},"page":"e37066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["CD133+\/ABCC5+ cervical cancer cells exhibit cancer stem cell properties"],"prefix":"10.1016","volume":"10","author":[{"given":"Lin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengjun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayinuer","family":"seyiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengshaoxiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingxu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxiang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2024.e37066_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca - Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37066_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca - Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37066_bib3","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37066_bib4","first-page":"17","article-title":"Miller KD. Wagle NS. Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"Ca - Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37066_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin Med J (Engl)."},{"key":"10.1016\/j.heliyon.2024.e37066_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/413076","article-title":"Paclitaxel and its evolving role in the management of ovarian cancer","volume":"2015","author":"Kampan","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37066_bib7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.bbrc.2018.12.048","article-title":"Disruption of protein neddylation with MLN4924 attenuates paclitaxel-induced apoptosis and microtubule polymerization in ovarian cancer cells","volume":"508","author":"Hong","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37066_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2015.12.006","article-title":"Microtubule-stabilizing agents: new drug discovery and cancer therapy","volume":"16","author":"Zhao","year":"2016","journal-title":"Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37066_bib9","first-page":"130","article-title":"FOXM1 binds directly to non-consensus sequences in the human genome","volume":"16","author":"Deborah","year":"2015","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37066_bib10","first-page":"1","article-title":"Dario B. Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells","volume":"14","author":"Deborah","year":"2013","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37066_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/leu.2015.334","article-title":"FOXM1 is a therapeutic target for high-risk multiple myeloma","volume":"30","author":"Gu","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.heliyon.2024.e37066_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","article-title":"Stem cells fate in cancer growth, progression and therapy resistance","volume":"18","author":"Lytle","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37066_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2018.09.003","article-title":"Pai V. Cancer stem cells, CD44, and outcomes following chemoradiation in locally advanced cervical cancer: results from a prospective study","volume":"103","author":"Chopra","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37066_bib14","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.31557\/APJCP.2021.22.12.4057","article-title":"The prognostic value of cancer stem cell markers in cervical cancer: a systematic review and meta-analysis","volume":"22","author":"Fahmi","year":"2021","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.heliyon.2024.e37066_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.126964","article-title":"Synthesis of guggulsterone derivatives as potential anti-austerity agents against PANC-1 human pancreatic cancer cells","author":"Kohyama","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37066_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.2019-0517","article-title":"The clinical impact of cancer stem cells","volume":"25","author":"Lathia","year":"2020","journal-title":"Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37066_bib17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2016.11.015","article-title":"Diffusion-weighted magnetic resonance imaging as a predictor of outcome in cervical cancer after chemoradiation","volume":"97","author":"Ho","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37066_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000493129","article-title":"CD44+\/CD24+-Expressing cervical cancer cells and radioresistant cervical cancer cells exhibit cancer stem cell characteristics","volume":"84","author":"Zhang","year":"2019","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.heliyon.2024.e37066_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.53","article-title":"The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells","volume":"8","author":"Hou","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e37066_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3032590","article-title":"FOXM1 promotes drug resistance in cervical cancer cells by regulating ABCC5 gene transcription","volume":"2022","author":"Hou","year":"2022","journal-title":"BioMed Res. Int."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37066_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12519-019-00271-1","article-title":"Forkhead box M1 transcription factor: a novel target for pulmonary arterial hypertension therapy","volume":"16","author":"Gu","year":"2020","journal-title":"World J Pediatr"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37066_bib22","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3390\/cancers12092677","article-title":"Suppression of tumor growth, metastasis, and signaling pathways by reducing FOXM1 activity in triple negative breast cancer","volume":"12","author":"Dey","year":"2020","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.heliyon.2024.e37066_bib23","article-title":"Varied clinical significance of ATP-binding cassette C sub-family members for lung adenocarcinoma","volume":"100","author":"Zhang","year":"2021","journal-title":"Medicine (Baltim.)"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37066_bib24","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.7150\/ijbs.59559","article-title":"Upregulation of ATP binding cassette subfamily C member 5 facilitates prostate cancer progression and enzalutamide resistance via the CDK1-mediated AR Ser81 phosphorylation pathway","volume":"17","author":"Ji","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37066_bib25","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41467-023-37379-y","article-title":"Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis","volume":"14","author":"Quah","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37066_bib26","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.3390\/ijms23095167","article-title":"Cancer stem cells and their possible implications in cervical cancer: a short review","volume":"23","author":"Di Fiore","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e37066_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/nature13305","article-title":"SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma","volume":"511","author":"Boumahdi","year":"2014","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e37066_bib28","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1200\/JCO.2014.58.4391","article-title":"Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical Cancer\uff1aThe open-label randomized phase \u2162 trial JCOG0505","volume":"33","author":"Kitagawa","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37066_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3802\/jgo.2010.21.2.93","article-title":"Carboplatin and paclitaxel as an initial treatment in patients with stage \u2163b cervical cancer\uff1aa report of 7 cases and a review of the literature","volume":"21","author":"Mabuchi","year":"2010","journal-title":"J Gynecol Oncol."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e37066_bib30","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2004.04.170","article-title":"Phase \u2162 study of cisplatin with or without paclitaxel in stage \u2163B\uff0crecurrent\uff0c or persistent squamous cell carcinoma of the cervix\uff1aa gynecologic oncology group study","volume":"22","author":"Moore","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37066_bib31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37066_bib32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00280-017-3398-2","article-title":"Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy","volume":"80","author":"Shi","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37066_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/cancers13051055","article-title":"Silencing CDCA8 suppresses hepatocellular carcinoma growth and stemness via restoration of ATF3 tumor suppressor and inactivation of AKT\/\u03b2catenin signaling","volume":"13","author":"Jeon","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37066_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41419-021-03405-4","article-title":"Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37066_bib35","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/tox.23296","article-title":"Inhibition of the notch signaling pathway overcomes resistance of cervical cancer cells to paclitaxel through retardation of the epithelial-mesenchymal transition process","volume":"36","author":"Sun","year":"2021","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37066_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ddr.21852","article-title":"Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagy","volume":"83","author":"Wang","year":"2022","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37066_bib37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.7150\/jca.76671","article-title":"FoxM1 knockdown enhanced radiosensitivity of esophageal cancer by inducing apoptosis","volume":"14","author":"Qin","year":"2023","journal-title":"J. Cancer"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37066_bib38","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1158\/0008-5472.CAN-16-3566","article-title":"FOXM1 in cancer: interactions and vulnerabilities","volume":"77","author":"Gartel","year":"2017","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37066_bib39","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00432-020-03438-w","article-title":"The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor","volume":"147","author":"Shibui","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e37066_bib40","doi-asserted-by":"crossref","first-page":"9857","DOI":"10.2147\/CMAR.S270825","article-title":"FoxM1 is upregulated in osteosarcoma and inhibition of FoxM1 decreases osteosarcoma cell proliferation, migration, and invasion","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37066_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/cancers11020251","article-title":"Pan-cancer analyses reveal genomic features of FOXM1 overexpression in cancer","volume":"11","author":"Barger","year":"2019","journal-title":"Cancers"},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2024.e37066_bib42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejps.2009.04.001","article-title":"Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513","volume":"37","author":"Salphati","year":"2009","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2024.e37066_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ejmech.2017.08.023","article-title":"Acridone-pyrimidine hybrids-design\uff0csynthesis\uff0ccytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies","volume":"139","author":"Murahari","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37066_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.290","article-title":"SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2","volume":"6","author":"Sun","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e37066_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145000","article-title":"Rucaparib antagonize multidrug resistance in cervical cancer cells through blocking the function of ABC transporters","volume":"759","author":"Chen","year":"2020","journal-title":"Gene"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024130976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024130976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:28:10Z","timestamp":1790544490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024130976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024130976"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37066","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD133+\/ABCC5+ cervical cancer cells exhibit cancer stem cell properties","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37066"}}